Amicogen Inc Cash Flow-to-Debt Ratio
Amicogen Inc cash flow-to-debt ratio. Amicogen Inc (092040) has a Cash Flow-to-Debt Ratio of -0.04x as of March 2026, meaning its operating cash flow of ₩-3.58 Billion could theoretically repay 0% of its total liabilities (₩80.33 Billion) in one year. Check 092040 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Amicogen Inc (2014–2025)
Cash flow-to-debt ratio of Amicogen Inc from 2014 to 2025. Historical debt coverage capacity for Amicogen Inc across 12 annual periods. Check Amicogen Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Amicogen Inc Cash Flow-to-Debt Ratio by Year (2014–2025)
Amicogen Inc cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Amicogen Inc. For the full cash flow conversion analysis, see 092040 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | ₩-24.42 Billion | ₩136.00 Billion | ▼ -131.3% |
| 2024 | -0.08x | ₩-13.34 Billion | ₩171.73 Billion | ▼ -322.9% |
| 2023 | 0.03x | ₩8.64 Billion | ₩248.12 Billion | ▲ +146.3% |
| 2022 | -0.08x | ₩-22.41 Billion | ₩297.86 Billion | ▼ -309.8% |
| 2021 | 0.04x | ₩8.07 Billion | ₩225.06 Billion | ▼ -47.2% |
| 2020 | 0.07x | ₩8.87 Billion | ₩130.43 Billion | ▼ -7.4% |
| 2019 | 0.07x | ₩8.76 Billion | ₩119.35 Billion | ▲ +168.6% |
| 2018 | 0.03x | ₩2.84 Billion | ₩103.93 Billion | ▼ -82.9% |
| 2017 | 0.16x | ₩11.88 Billion | ₩74.32 Billion | ▼ -8.1% |
| 2016 | 0.17x | ₩11.28 Billion | ₩64.79 Billion | ▲ +9.6% |
| 2015 | 0.16x | ₩12.34 Billion | ₩77.74 Billion | ▼ -84.4% |
| 2014 | 1.02x | ₩4.43 Billion | ₩4.35 Billion | — |